EUVIMEDEUVIMED entdecken
Crossref

A case of acute hyperammonemic encephalopathy after initiation of 5-fluorouracil chemotherapy

Timothy Daly, Zarian Prenatt, Hannah Sagin, Sally Wen, Kashyap Shah, Subhash Proothi, Prabhdeep Hehar

American Journal of Pharmacotherapy and Pharmaceutical Sciences · 2022

DOI: 10.25259/ajpps_16_2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Pharmacotherapy and Pharmaceutical Sciences, 2022. Verfasst von Timothy Daly und 6 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-fluorouracil is a chemotherapeutic agent that has been used for decades to treat a number of neoplasms. It has a number of adverse effects; however, we present a case of a seldom reported side effect in hyperammonemic encephalopathy that should be considered in patients presenting with altered mental status shortly after starting therapy.

Zitieren

APA

Daly, T., Prenatt, Z., Sagin, H., Wen, S., Shah, K., Proothi, S., & Hehar, P. (2022). A case of acute hyperammonemic encephalopathy after initiation of 5-fluorouracil chemotherapy. American Journal of Pharmacotherapy and Pharmaceutical Sciences. https://doi.org/10.25259/ajpps_16_2022

Vancouver

Daly T, Prenatt Z, Sagin H, Wen S, Shah K, Proothi S, et al. A case of acute hyperammonemic encephalopathy after initiation of 5-fluorouracil chemotherapy. American Journal of Pharmacotherapy and Pharmaceutical Sciences. 2022. doi:10.25259/ajpps_16_2022

BibTeX
@article{Daly2022,
  author = {Daly, Timothy and Prenatt, Zarian and Sagin, Hannah and Wen, Sally and Shah, Kashyap and Proothi, Subhash and Hehar, Prabhdeep},
  title = {A case of acute hyperammonemic encephalopathy after initiation of 5-fluorouracil chemotherapy},
  journal = {American Journal of Pharmacotherapy and Pharmaceutical Sciences},
  year = {2022},
  doi = {10.25259/ajpps_16_2022}
}
Kostenlos starten →